A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer

PURPOSE: PANVAC is a recombinant poxviral vaccine that contains transgenes for MUC-1, CEA and 3 T-cell costimulatory molecules. This study was conducted to obtain preliminary evidence of clinical response in metastatic breast and ovarian cancer patients. EXPERIMENTAL DESIGN: Twenty-six patients were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mohebtash, Mahsa, Tsang, Kwong-Yok, Madan, Ravi A., Huen, Ngar-Yee, Poole, Diane J., Jochems, Caroline, Jones, Jacquin, Ferrara, Theresa, Heery, Christopher R., Arlen, Philip M., Steinberg, Seth M., Pazdur, Mary, Rauckhorst, Myrna, Jones, Elizabeth C., Dahut, William L., Schlom, Jeffrey, Gulley, James L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227395/
https://ncbi.nlm.nih.gov/pubmed/22068656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0649
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados